CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR, the disruptor : Nature News & Comment
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR-Cas 9 corrects genetic defects in mice
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR, the disruptor : Nature News & Comment
CRISPR algorithm predicts how well gene editing will work - Scope
The kill-switch for CRISPR that could make gene-editing safer
Untangling the CRISPR cancer scare
Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Focus on CRISPR tools and therapies | Nature Biotechnology
